Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the KEEPsAKE 2 Randomized Clinical Trial.
Östör A, Van den Bosch F, Papp K, Asnal C, Blanco R, Aelion J, Carter K, Stakias V, Lippe R, Drogaris L, Soliman AM, Chen MM, Padilla B, Kivitz A.
Östör A, et al. Among authors: soliman am.
Rheumatol Ther. 2024 Mar 18. doi: 10.1007/s40744-024-00657-2. Online ahead of print.
Rheumatol Ther. 2024.
PMID: 38498139
Free article.